Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense
Science · 2023
DOI: 10.1126/science.abm1184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2023. Verfasst von Arica R VanderWal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Viral, Bacterial Proteins, Endodeoxyribonucleases. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Type VI CRISPR-Cas systems use RNA-guided ribonuclease (RNase) Cas13 to defend bacteria against viruses, and some of these systems encode putative membrane proteins that have unclear roles in Cas13-mediated defense. We show that Csx28, of type VI-B2 systems, is a transmembrane protein that assists to slow cellular metabolism upon viral infection, increasing antiviral defense. High-resolution cryo–electron microscopy reveals that Csx28 forms an octameric pore-like structure. These Csx28 pores localize to the inner membrane in vivo. Csx28’s antiviral activity in vivo requires sequence-specific cleavage of viral messenger RNAs by Cas13b, which subsequently results in membrane depolarization, slowed metabolism, and inhibition of sustained viral infection. Our work suggests a mechanism by which Csx28 acts as a downstream, Cas13b-dependent effector protein that uses membrane perturbation as an antiviral defense strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
- Center for RNA Biology, University of Rochester, Rochester, NY, USA.
- Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
ORCID-Profile: Arica R VanderWal, Jung-Un Park, Bogdan Polevoda, Adrian M Molina Vargas, Elizabeth H Kellogg, Mitchell R O'Connell
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIDCR NIH HHS
Zitieren
APA
VanderWal, A. R., Park, J. U., Polevoda, B., Nicosia, J. K., Molina Vargas, A. M., Kellogg, E. H., & O'Connell, M. R. (2023). Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense. Science. https://doi.org/10.1126/science.abm1184
Vancouver
VanderWal AR, Park JU, Polevoda B, Nicosia JK, Molina Vargas AM, Kellogg EH, et al. Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense. Science. 2023. doi:10.1126/science.abm1184
BibTeX
@article{VanderWal2023,
author = {VanderWal, Arica R and Park, Jung-Un and Polevoda, Bogdan and Nicosia, Julia K and Molina Vargas, Adrian M and Kellogg, Elizabeth H and O'Connell, Mitchell R},
title = {Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense},
journal = {Science},
year = {2023},
doi = {10.1126/science.abm1184}
}
EUVIMED